Profile data is unavailable for this security.
About the company
Dawnrays Pharmaceutical (Holdings) Limited is an investment holding company principally engaged in the development, manufacture and sale of non-patented pharmaceutical medicines. The products include intermediate pharmaceutical, bulk medicines and finished drugs. The Company operates its business through two segments. The Intermediates and Bulk Medicines segment is engaged in the manufacture and sale of intermediates and bulk medicines. The Finished Drugs segment is engaged in the manufacture and sale of finished drugs, including antibiotics finished drugs and non-antibiotics finished drugs.
- Revenue in HKD (TTM)1.36bn
- Net income in HKD418.08m
- Incorporated2002
- Employees1.06k
- LocationDawnrays Pharmaceutical (Holdings) LtdUnits 3001-02, 30/F, CNT Tower, Wanchai Hong KongHKG
- Phone+852 21119708
- Fax+852 21119870
- Websitehttp://www.dawnrays.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Transcenta Holding Limited | 52.16m | -1.06bn | 1.07bn | 321.00 | -- | 0.5513 | -- | 20.45 | -2.40 | -2.40 | 0.1185 | 4.55 | 0.0194 | 1.65 | 4.56 | 143,702.30 | -39.61 | -- | -48.08 | -- | 17.48 | -- | -2,040.65 | -- | 2.63 | -47.97 | 0.1908 | -- | -37.96 | -- | -441.82 | -- | -- | -- |
| Genor Biopharma Holdings Ltd | 3.40m | -1.00bn | 1.15bn | 452.00 | -- | 0.4701 | -- | 337.37 | -2.01 | -2.01 | 0.0068 | 4.83 | 0.001 | 0.0175 | 0.029 | 5,316.83 | -30.50 | -- | -33.43 | -- | 73.38 | -- | -29,412.99 | -- | 8.33 | -- | 0.0252 | -- | -100.00 | -- | 71.42 | -- | -- | -- |
| TOT Biopharm International Co Ltd | 270.76m | -186.41m | 1.38bn | 355.00 | -- | 2.90 | -- | 5.08 | -0.3241 | -0.3241 | 0.4707 | 0.614 | 0.3254 | 1.65 | 5.40 | 803,448.60 | -22.41 | -- | -34.33 | -- | 73.14 | -- | -68.85 | -- | 0.8533 | -14.00 | 0.4296 | -- | 239.36 | -- | 9.46 | -- | -- | -- |
| JW (Cayman) Therapeutics Co Ltd | 111.44m | -979.49m | 1.53bn | 589.00 | -- | 0.51 | -- | 13.72 | -2.41 | -2.41 | 0.2743 | 7.29 | 0.0304 | 3.11 | 2.83 | 208,679.90 | -26.67 | -- | -28.28 | -- | 33.24 | -- | -878.98 | -- | 9.74 | -10.52 | 0.0545 | -- | -- | -- | 57.79 | -- | -- | -- |
| Hbm Holdings Ltd | 233.33m | -1.17bn | 1.69bn | 365.00 | -- | 1.33 | -- | 7.24 | -1.60 | -1.60 | 0.318 | 1.66 | 0.0998 | -- | 25.77 | 606,055.30 | -50.15 | -- | -57.13 | -- | 99.31 | -- | -502.40 | -- | -- | -- | 0.2826 | -- | -69.46 | -- | 53.52 | -- | -- | -- |
| Jacobson Pharma Corporation Ltd | 1.66bn | 233.82m | 1.74bn | 1.80k | 7.38 | 0.6776 | 3.96 | 1.05 | 0.1219 | 0.1219 | 0.8672 | 1.33 | 0.3361 | 2.80 | 5.95 | 957,651.50 | 5.10 | 4.96 | 6.65 | 6.88 | 41.39 | 41.41 | 15.17 | 13.74 | 3.09 | 10.16 | 0.3414 | 32.46 | 10.35 | 4.90 | 2.28 | -0.186 | -7.11 | 12.02 |
| Abbisko Cayman Ltd | 0.00 | -570.51m | 1.88bn | 192.00 | -- | 0.6963 | -- | -- | -0.9482 | -0.9482 | 0.00 | 3.85 | 0.00 | -- | -- | -- | -19.27 | -- | -19.97 | -- | -- | -- | -- | -- | -- | -- | 0.019 | -- | -100.00 | -- | 72.62 | -- | -- | -- |
| Golden Throat Holdings Group Co Ltd | 874.14m | 187.48m | 1.91bn | 937.00 | 10.17 | 1.26 | 8.25 | 2.18 | 0.2536 | 0.2536 | 1.18 | 2.05 | 0.4231 | 2.58 | 3.17 | 932,909.40 | 9.07 | 8.57 | 12.64 | 12.02 | 69.69 | 72.68 | 21.45 | 18.78 | 2.38 | 159.04 | 0.1806 | 56.25 | 26.83 | 1.33 | 21.80 | 12.76 | 44.82 | 22.25 |
| SinoMab Bioscience Ltd | 0.00 | -327.11m | 1.91bn | 296.00 | -- | 3.26 | -- | -- | -0.3298 | -0.3298 | 0.00 | 0.5668 | 0.00 | -- | -- | -- | -27.72 | -25.55 | -32.21 | -28.89 | -- | -- | -- | -4,070.71 | -- | -6.12 | 0.4121 | -- | -100.00 | -- | 1.40 | -- | -- | -- |
| Dawnrays Pharmaceutical Holdings Ltd | 1.36bn | 418.08m | 2.01bn | 1.06k | 4.83 | 0.7055 | 4.12 | 1.48 | 0.2773 | 0.2773 | 0.9013 | 1.90 | 0.3839 | 2.39 | 7.00 | 1,275,490.00 | 11.72 | 11.45 | 13.95 | 13.83 | 59.26 | 58.71 | 30.53 | 29.60 | 2.31 | 20.12 | 0.0105 | 42.68 | 13.75 | 7.17 | 33.58 | 6.14 | 65.21 | 2.29 |
| Antengene Corporation Ltd | 95.23m | -652.68m | 2.05bn | 383.00 | -- | 0.7943 | -- | 21.54 | -1.05 | -1.05 | 0.1532 | 3.83 | 0.0307 | 2.90 | 1.68 | 289,447.20 | -21.02 | -- | -22.36 | -- | 83.94 | -- | -685.39 | -- | 11.13 | -- | 0.0156 | -- | -- | -- | 77.62 | -- | -- | -- |
| Zhaoke Ophthalmology Ltd | 0.00 | -348.97m | 2.06bn | 268.00 | -- | 0.72 | -- | -- | -0.6442 | -0.6442 | 0.00 | 5.25 | 0.00 | -- | -- | 0.00 | -11.24 | -- | -11.70 | -- | -- | -- | -- | -- | -- | -127.18 | 0.0247 | -- | -- | -- | -192.96 | -- | -- | -- |
| Essex Bio-Technology Ltd | 1.32bn | 225.41m | 2.13bn | 1.42k | 9.75 | 1.23 | 7.99 | 1.62 | 0.3827 | 0.3827 | 2.20 | 3.03 | 0.4727 | 1.42 | 2.34 | -- | 8.09 | 12.32 | 10.42 | 16.13 | 90.26 | 84.29 | 17.11 | 20.72 | 2.02 | -- | 0.2205 | 15.58 | -19.54 | 7.93 | -34.85 | 6.14 | -- | 5.39 |
| Mabpharm Ltd | 35.09m | -303.20m | 2.23bn | 389.00 | -- | 3.94 | -- | 63.47 | -0.0735 | -0.0735 | 0.0085 | 0.1371 | 0.0318 | 0.1875 | 3.98 | 72,500.48 | -27.48 | -- | -35.08 | -- | 63.71 | -- | -864.06 | -- | 0.6451 | -32.37 | 0.205 | -- | -- | -- | -58.01 | -- | -- | -- |
| Clover Biopharmaceuticals Ltd | 0.00 | -6.72bn | 2.50bn | 814.00 | -- | 11.03 | -- | -- | -12.92 | -12.92 | 0.00 | 0.175 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 1.29 | -0.7857 | 0.3124 | -- | -- | -- | -559.03 | -- | -- | -- |
| Immunotech Biopharm Ltd | 0.00 | -399.74m | 2.50bn | 267.00 | -- | 3.17 | -- | -- | -0.7768 | -0.7768 | 0.00 | 1.53 | 0.00 | -- | -- | 0.00 | -33.66 | -- | -37.53 | -- | -- | -- | -- | -- | 1.49 | -18.73 | 0.1291 | -- | -- | -- | 19.32 | -- | -- | -- |
Data as of Mar 28 2023. Currency figures normalised to Dawnrays Pharmaceutical (Holdings) Ltd's reporting currency: Hong Kong Dollar HKD
10.69%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fidelity Management & Research Co. LLCas of 30 Sep 2021 | 91.68m | 6.12% |
| UBS Asset Management (Hong Kong) Ltd.as of 31 Aug 2022 | 37.04m | 2.47% |
| Dimensional Fund Advisors LPas of 02 Mar 2023 | 13.29m | 0.89% |
| Fidelity Investments Canada ULCas of 31 Jan 2023 | 11.01m | 0.73% |
| CATAM Asset Management AGas of 31 Mar 2021 | 3.23m | 0.22% |
| FIAM LLCas of 31 Jan 2023 | 2.35m | 0.16% |
| Dimensional Fund Advisors Ltd.as of 31 May 2022 | 707.89k | 0.05% |
| LGT Capital Partners AG (Investment Management)as of 30 Nov 2021 | 440.00k | 0.03% |
| Acadian Asset Management LLCas of 31 Jan 2023 | 263.95k | 0.02% |
| FIL Investments Internationalas of 30 Jun 2022 | 142.00k | 0.01% |
More ▼
Data from 31 Dec 2022 - 16 Mar 2023Source: FactSet Research Systems Inc.
